Tocqueville Asset Management L.P. Novartis Ag Transaction History

Tocqueville Asset Management L.P.

$6.27 Billion
Q3 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Novartis Ag stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 107,518 shares of NVS stock, worth $11.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

107,518

Previous 110,276 2.5%

Holding current value

$11.2 Million

Previous $11.7 Million 5.34%

% of portfolio

0.2%

Previous 0.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$106.13 - $120.89 $292,706 - $333,414	-2,758 Reduced 2.5%	107,518 $12.4 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $160,794 - $186,501	1,737 Added 1.6%	110,276 $11.7 Million
Q1 2024 May 09, 2024	BUY	$95.27 - $108.47 $47,920 - $54,560	503 Added 0.47%	108,539 $10.5 Million
Q4 2023 Feb 12, 2024	SELL	$92.27 - $101.54 $665,728 - $732,611	-7,215 Reduced 6.26%	108,036 $10.9 Million
Q3 2023 Nov 09, 2023	BUY	$94.73 - $105.13 $60,627 - $67,283	640 Added 0.56%	115,251 $11.7 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $5.89 Million - $6.67 Million	-63,613 Reduced 35.69%	114,611 $11.6 Million
Q1 2023 May 10, 2023	SELL	$80.03 - $92.81 $247,852 - $287,432	-3,097 Reduced 1.71%	178,224 $16.4 Million
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $4,381 - $5,366	-58 Reduced 0.03%	181,321 $16.4 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $244,795 - $286,300	-3,281 Reduced 1.78%	181,379 $13.8 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $15,459 - $18,000	-192 Reduced 0.1%	184,660 $15.6 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $647,689 - $732,662	-8,085 Reduced 4.19%	184,852 $16.2 Million
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $4.56 Million - $5.04 Million	-57,164 Reduced 22.86%	192,937 $16.9 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $152,356 - $177,245	-1,863 Reduced 0.74%	250,101 $20.5 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $3.9 Million - $4.3 Million	-45,703 Reduced 15.35%	251,964 $23 Million
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $803,938 - $948,069	-9,628 Reduced 3.13%	297,667 $25.4 Million
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $503,551 - $609,073	-6,450 Reduced 2.06%	307,295 $29 Million
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $515,264 - $570,843	-6,273 Reduced 1.96%	313,745 $27.3 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $3.03 Million - $3.41 Million	37,475 Added 13.26%	320,018 $28 Million
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $1,908 - $2,673	-27 Reduced 0.01%	282,543 $23.3 Million
Q4 2019 Jan 14, 2020	SELL	$84.35 - $95.37 $6.03 Million - $6.82 Million	-71,531 Reduced 20.2%	282,570 $26.8 Million
Q3 2019 Oct 31, 2019	SELL	$85.54 - $94.26 $2.43 Million - $2.68 Million	-28,404 Reduced 7.43%	354,101 $30.8 Million
Q2 2019 Jul 31, 2019	SELL	$75.4 - $92.8 $1.63 Million - $2.01 Million	-21,679 Reduced 5.36%	382,505 $34.9 Million
Q1 2019 Apr 30, 2019	SELL	$75.32 - $86.15 $4.89 Million - $5.59 Million	-64,944 Reduced 13.84%	404,184 $38.9 Million
Q4 2018 Feb 08, 2019	SELL	$73.66 - $82.02 $4.72 Million - $5.25 Million	-64,022 Reduced 12.01%	469,128 $40.3 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $476,545 - $551,224	7,119 Added 1.35%	533,150 $45.9 Million
Q2 2018 Aug 13, 2018	BUY	$64.91 - $73.36 $1.03 Million - $1.16 Million	15,800 Added 3.1%	526,031 $39.7 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $3.66 Million - $4.38 Million	-51,995 Reduced 9.25%	510,231 $41.3 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $2.25 Million - $2.41 Million	31,070 Added 5.85%	562,226 $47.2 Million
Q3 2017 Oct 30, 2017	BUY	$74.14 - $77.27 $39.4 Million - $41 Million	531,156	531,156 $45.6 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Novartis Ag Transaction History